Your browser doesn't support javascript.
loading
Characterization of ABBV-221, a Tumor-Selective EGFR-Targeting Antibody Drug Conjugate.
Phillips, Andrew C; Boghaert, Erwin R; Vaidya, Kedar S; Falls, Hugh D; Mitten, Michael J; DeVries, Peter J; Benatuil, Lorenzo; Hsieh, Chung-Ming; Meulbroek, Jonathan A; Panchal, Sanjay C; Buchanan, Fritz G; Durbin, Kenneth R; Voorbach, Martin J; Reuter, David R; Mudd, Sarah R; Loberg, Lise I; Ralston, Sherry L; Cao, Diana; Gan, Hui K; Scott, Andrew M; Reilly, Edward B.
Afiliação
  • Phillips AC; AbbVie Inc., North Chicago, Illinois.
  • Boghaert ER; AbbVie Inc., North Chicago, Illinois.
  • Vaidya KS; AbbVie Inc., North Chicago, Illinois.
  • Falls HD; AbbVie Inc., North Chicago, Illinois.
  • Mitten MJ; AbbVie Inc., North Chicago, Illinois.
  • DeVries PJ; AbbVie Inc., North Chicago, Illinois.
  • Benatuil L; AbbVie Bioresearch Center, Worcester, Massachusetts.
  • Hsieh CM; AbbVie Bioresearch Center, Worcester, Massachusetts.
  • Meulbroek JA; AbbVie Inc., North Chicago, Illinois.
  • Panchal SC; AbbVie Inc., North Chicago, Illinois.
  • Buchanan FG; AbbVie Inc., North Chicago, Illinois.
  • Durbin KR; AbbVie Inc., North Chicago, Illinois.
  • Voorbach MJ; AbbVie Inc., North Chicago, Illinois.
  • Reuter DR; AbbVie Inc., North Chicago, Illinois.
  • Mudd SR; AbbVie Inc., North Chicago, Illinois.
  • Loberg LI; AbbVie Inc., North Chicago, Illinois.
  • Ralston SL; AbbVie Inc., North Chicago, Illinois.
  • Cao D; Olivia Newton-John Cancer Research Institute, and La Trobe University Austin Hospital, Heidelberg, Victoria, Australia.
  • Gan HK; Olivia Newton-John Cancer Research Institute, and La Trobe University Austin Hospital, Heidelberg, Victoria, Australia.
  • Scott AM; Olivia Newton-John Cancer Research Institute, and La Trobe University Austin Hospital, Heidelberg, Victoria, Australia.
  • Reilly EB; AbbVie Inc., North Chicago, Illinois. ed.reilly@abbvie.com.
Mol Cancer Ther ; 17(4): 795-805, 2018 04.
Article em En | MEDLINE | ID: mdl-29483208

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oligopeptídeos / Glioblastoma / Imunoconjugados / Anticorpos Monoclonais Humanizados Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oligopeptídeos / Glioblastoma / Imunoconjugados / Anticorpos Monoclonais Humanizados Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article